A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants

Abstract : Cefotaxime is one of the most frequently prescribed antibiotics for the treatment of Gram-negative bacterial sepsis in neonates. However, the dosing regimens routinely used in clinical practice vary considerably. The objective of the present study was to conduct a population pharmacokinetic study of cefotaxime in neonates and young infants in order to evaluate and optimize the dosing regimen. An opportunistic sampling strategy combined with population pharmacokinetic analysis using NONMEM software was performed. Cefotaxime concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry. Developmental pharmacokinetics-pharmacodynamics, the microbiological pathogens, and safety aspects were taken into account to optimize the dose. The pharmacokinetic data from 100 neonates (gestational age [GA] range, 23 to 42 weeks) were modeled with an allometric two-compartment model with first-order elimination. The median values for clearance and the volume of distribution at steady state were 0.12 liter/h/kg of body weight and 0.64 liter/kg, respectively. The covariate analysis showed that current weight, GA, and postnatal age (PNA) had significant impacts on cefotaxime pharmacokinetics. Monte Carlo simulations demonstrated that the current dose recommendations underdosed older newborns. A model-based dosing regimen of 50 mg/kg twice a day to four times a day, according to GA and PNA, was established. The associated risk of overdose for the proposed dosing regimen was 0.01%. We determined the population pharmacokinetics of cefotaxime and established a model-based dosing regimen to optimize treatment for neonates and young infants.
Keywords : Périnatalité
Type de document :
Article dans une revue
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2016, 60 (11), pp.6626-6634. 〈10.1128/AAC.01045-16〉
Liste complète des métadonnées

Littérature citée [35 références]  Voir  Masquer  Télécharger

http://hal.univ-reunion.fr/hal-01477003
Contributeur : Réunion Univ <>
Soumis le : jeudi 28 juin 2018 - 12:44:37
Dernière modification le : jeudi 28 juin 2018 - 12:58:24

Fichier

Population_and_developmental_p...
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Stéphanie Leroux, Jean-Michel Roué, Jean-Bernard Gouyon, Valérie Biran, Hao Zheng, et al.. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2016, 60 (11), pp.6626-6634. 〈10.1128/AAC.01045-16〉. 〈hal-01477003〉

Partager

Métriques

Consultations de la notice

164

Téléchargements de fichiers

7